These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 34021680

  • 61. Salt intake in mineralocorticoid receptor antagonist-treated primary aldosteronism: foe or ally?
    Fountoulakis S, Papanastasiou L, Voulgaris N, Kounadi T, Markou A, Chrousos GP, Piaditis G.
    Hormones (Athens); 2020 Jun; 19(2):223-232. PubMed ID: 31863347
    [Abstract] [Full Text] [Related]

  • 62. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
    Sakallı H, Baskın E, Bayrakcı US, Moray G, Haberal M.
    Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308
    [Abstract] [Full Text] [Related]

  • 63. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL, Pitt B, Weir MR, Freeman MW, Mayo MR, Garza D, Stasiv Y, Zawadzki R, Berman L, Bushinsky DA, AMETHYST-DN Investigators.
    JAMA; 2015 Jul 14; 314(2):151-61. PubMed ID: 26172895
    [Abstract] [Full Text] [Related]

  • 64. [Infantile transitory distal renal tubular acidosis with bicarbonate loss].
    Schabel F, Irnberger E.
    Padiatr Padol; 1985 Jul 14; 20(4):353-62. PubMed ID: 2867514
    [Abstract] [Full Text] [Related]

  • 65. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
    Pelleya R, Oster JR, Perez GO.
    Am J Nephrol; 1983 Jul 14; 3(4):223-7. PubMed ID: 6351617
    [Abstract] [Full Text] [Related]

  • 66. Correction of hyperkalemia by bicarbonate despite constant blood pH.
    Fraley DS, Adler S.
    Kidney Int; 1977 Nov 14; 12(5):354-60. PubMed ID: 24132
    [Abstract] [Full Text] [Related]

  • 67. Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.
    Bertocchio JP, Barbe C, Lavaud S, Toupance O, Nazeyrollas P, Jaisser F, Rieu P.
    PLoS One; 2016 Nov 14; 11(4):e0153635. PubMed ID: 27088859
    [Abstract] [Full Text] [Related]

  • 68. Hyperkalemia and Hypertension Post Organ Transplantation - A Management Challenge.
    Hamrahian SM, Fülöp T.
    Am J Med Sci; 2021 Jan 14; 361(1):106-110. PubMed ID: 32709394
    [Abstract] [Full Text] [Related]

  • 69. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
    Basri N, Gendo MZ, Haider R, Abdullah KA, Hassan A, Shaheen FA.
    Exp Clin Transplant; 2007 Jun 14; 5(1):607-9. PubMed ID: 17617052
    [Abstract] [Full Text] [Related]

  • 70. Gluco- and mineralocorticoid biological effects of a 7-day treatment with low doses of hydrocortisone and fludrocortisone in septic shock.
    Laviolle B, Annane D, Fougerou C, Bellissant E.
    Intensive Care Med; 2012 Aug 14; 38(8):1306-14. PubMed ID: 22584796
    [Abstract] [Full Text] [Related]

  • 71. Potassium abnormalities in a pediatric intensive care unit: frequency and severity.
    Cummings BM, Macklin EA, Yager PH, Sharma A, Noviski N.
    J Intensive Care Med; 2014 Aug 14; 29(5):269-74. PubMed ID: 23753253
    [Abstract] [Full Text] [Related]

  • 72. Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation.
    Jones JW, Gruessner RW, Gores PF, Matas AJ.
    Transplantation; 1993 Oct 14; 56(4):1013-5. PubMed ID: 8212180
    [No Abstract] [Full Text] [Related]

  • 73. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia.
    Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, Ross D, Rigsby M, Miller G.
    Transplantation; 1998 Feb 27; 65(4):583-5. PubMed ID: 9500639
    [Abstract] [Full Text] [Related]

  • 74. Hyperkalemia induced by indomethacin and naproxen and reversed by fludrocortisone.
    Mactier RA, Khanna R.
    South Med J; 1988 Jun 27; 81(6):799-801. PubMed ID: 3375885
    [Abstract] [Full Text] [Related]

  • 75. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE, Farrington CA, Wall GC, Belz MM.
    Clin Nephrol; 2016 Jan 27; 85(1):38-43. PubMed ID: 26587776
    [Abstract] [Full Text] [Related]

  • 76. Plasma electrolyte imbalance in pediatric kidney transplant recipients.
    Hayes W, Longley C, Scanlon N, Bryant W, Stojanovic J, Kessaris N, Van't Hoff W, Bockenhauer D, Marks SD.
    Pediatr Transplant; 2019 Jun 27; 23(4):e13411. PubMed ID: 30973673
    [Abstract] [Full Text] [Related]

  • 77. Life threatening hyperkalemia in a neonate with pseudo-hypoaldosteronism.
    Choudhry S, Najam Y.
    J Pak Med Assoc; 2012 Mar 27; 62(3):287-8. PubMed ID: 22764468
    [Abstract] [Full Text] [Related]

  • 78. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K, Flynn J, Okamura D, Zhou L.
    J Ren Nutr; 2013 Sep 27; 23(5):333-9. PubMed ID: 23707305
    [Abstract] [Full Text] [Related]

  • 79. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE, Cohen J, Vivera M, Zaltzman JS.
    Am J Kidney Dis; 2000 Jan 27; 35(1):58-63. PubMed ID: 10620545
    [Abstract] [Full Text] [Related]

  • 80. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ, Bravo Soto JA, Merino Pérez MJ, González Carmelo I, López Jiménez V, García Álvarez T, Acosta Martínez Y, Mazuecos Blanca MA.
    Nefrologia; 2015 Jan 27; 35(4):363-73. PubMed ID: 26306956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.